Some research suggests GLP-1 medications may benefit patients with cardiovascular disease by lowering blood pressure, improving cholesterol, and reducing inflammation
Week 5-12: Continued reduction in hunger and increased satiety
In contrast, when kits from different manufacturers were combined, the variation increased to 19% (total BDNF from R&D Systems and pro-BDNF from FineTest
[6] Tirzepatide (e.g., Zepbound, Mounjaro for off-label use): Also a once-weekly injectable, Tirzepatide is a unique dual agonist, meaning it mimics both GLP-1 and GIP (Glucose-dependent Insulinotropic Polypeptide)
At their previous pharmacy, 20 units delivered 0.5mg
However, we did find a small increased risk of NAION with exenatide use when using the specific NAION definition. Future research should incorporate ocular risk factors or examine dose-dependent effects to continue to investigate a potential causal relationship between semaglutide and NAION, they added